VXRT - Vaxart Inc. (VXRT) Q1 2024 Earnings Call Transcript
2024-05-13 17:49:08 ET
Vaxart, Inc. (VXRT)
Q1 2024 Earnings Conference Call
May 13, 2024 4:30 p.m. ET
Company Participants
Ed Berg - Senior Vice President and General Counsel
Steven Lo - Chief Executive Officer
Sean Tucker - Founder and Chief Scientific Officer
James Cummings - Chief Medical Officer
Phil Lee - Chief Financial Officer
Conference Call Participants
Madison Britt Wynne El-Saadi - B. Riley Securities
Aseah Khan - Cantor Fitzgerald
Liang Cheng - Jefferies
Presentation
Operator
Greetings, and welcome to the Vaxart Business Update and First Quarter 2024 Financial Results Conference Call. A question-and-answer session will follow management's opening remarks. Individual investors may submit written questions to ir@vaxart.com. As a reminder, this conference is being recorded.
I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel.
Ed Berg
Good afternoon, and welcome to today's call. Joining us from Vaxart are Steven Lo, Chief Executive Officer; Dr. Sean Tucker, Founder and Chief Scientific Officer; Dr. James Cummings, Chief Medical Officer; and Phillip Lee, Chief Financial Officer....
Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript